本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Protagonist Therapeutics Inc

143.40
-4.3800-2.96%
盤前143.800.4000+0.28%05:12 EDT
成交量:63.75萬
成交額:9,149.69萬
市值:92.79億
市盈率:139.22
高:147.99
開:147.48
低:142.00
收:147.78
52周最高:160.81
52周最低:57.90
股本:6,470.83萬
流通股本:6,316.60萬
量比:1.11
換手率:1.01%
股息:- -
股息率:- -
每股收益(TTM):1.03
每股收益(LYR):-2.0500
淨資產收益率:10.98%
總資產收益率:4.55%
市淨率:11.03
市盈率(LYR):-69.95

資料載入中...

2024/11/08

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/08

重要事件披露

Form 8-K - Current report
2024/10/16

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/09/20

重要事件披露

Form 8-K - Current report
2024/09/11

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/10

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/06

重要事件披露

Form 8-K - Current report
2024/07/24

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/26

重要事件披露

Form 8-K - Current report
2024/06/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/06/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/05/07

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/07

重要事件披露

Form 8-K - Current report
2024/04/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/03/01

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/02/27

員工持股計劃

Form S-8 - Securities to be offered to employees in employee benefit plans